FDA to Reassess Use of PD-1 Inhibitors in Stomach Cancer, Seeking Expert Input on Merck, BMS, and BeiGene Medications

FDA, PD-1 inhibitors, stomach cancer, Merck, BMS, BeiGene, Oncologic Drugs Advisory Committee, PD-L1 expression

SandboxAQ and Mayo Clinic Partner to Revolutionize Cardiac Diagnostics with AI-Powered Magnetocardiography

SandboxAQ, Mayo Clinic, AI-powered magnetocardiography, cardiac diagnostics, CardiAQ, medical imaging technology, quantum sensors, large quantitative models